2024-11-19 16:37:45
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting
Health/ 2023-07-22
Bioheng Announced Oral Presentation of I...

HANGZHOU and NANJING,China,Nov. 10,2020-- Bioheng Biotech Co.,Ltd,a clinical-stage biotechnology company focuses on developing novel cellula...

FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform
Health/ 2023-07-22
FibroGenesis Announces the Filing of its...

World Leader in Fibroblast Technology Advances Intellectual Property Position with their 250th Patent Filed Today

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release